Exports In 2022, Philippines exported $1.62M in Vaccines, blood, antisera, toxins and cultures, making it the 101st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 553rd most exported product in Philippines. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Philippines are: Singapore ($827k), Hong Kong ($461k), South Korea ($70.9k), China ($59.7k), and Ireland ($33.7k).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Philippines between 2021 and 2022 were Singapore ($810k), China ($57.5k), and Panama ($29.3k).
Imports In 2022, Philippines imported $722M in Vaccines, blood, antisera, toxins and cultures, becoming the 46th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 44th most imported product in Philippines. Philippines imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($177M), Belgium ($109M), Germany ($87.8M), France ($58.8M), and Spain ($53.6M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Philippines between 2021 and 2022 were Spain ($42.5M), Netherlands ($10.4M), and India ($4.33M).